All Posts Tagged With: "pharmaceuticals"
Ask Not For Whom the Drug Tolls
“Fifty years ago, it made sense to assert that mental illnesses are not diseases, but it makes no sense to say so today. Debate about what counts as mental illness has been replaced by legislation about the medicalization and demedicalization of behavior. Old diseases such as homosexuality and hysteria disappear. New diseases such as gambling [...]
22Dec2010 | Wendy McElroy | 13 comments | ContinuedCapital Letters
Don’t Let the Court Off the Hook To the Editor: As a former wartime draftee — the Korean War — I’m of two minds re Aeon J. Skoble’s “Neither Slavery Nor Involuntary Servitude” piece in your September issue (“It Just Ain’t So!). No question, he did a very good job of picking apart the operational [...]
6Jul2010 | FEE Admin | 1 comment | ContinuedBook Reviews – March 2008
- Myth of the Rational Voter: Why Democracies Choose Bad Policies
by Bryan Caplan Reviewed by Dwight Lee - The Science of Success: How Market-Based Management Built the World
1Mar2008 | George C. Leef | 1 comment | Continued
Health-Care Demagogues
Doug Bandow, a nationally syndicated columnist, is a senior fellow at the Cato Institute and the author and editor of several books. The Bush administration seems ready to push Medicare reform, and Republican legislators are committed to creating a pharmaceutical benefit. The congressional hopper is sure to fill with bills attacking the pharmaceutical industry and [...]
1May2003 | Doug Bandow | 0 comments | ContinuedEvaluating New Drugs: Remember the Bigger Picture
“Don’t be penny-wise and pound-foolish” is an old adage that cautions us about false savings. Sometimes spending a little more now makes the best sense if it maximizes our savings in the long run. Failure to understand this lesson is at the root of many misjudgments and bad policies swirling around prescription drugs these days. [...]
1Oct2002 | Lawrence W. Reed | 0 comments | ContinuedTo America’s Health: A Proposal to Reform the Food and Drug Administration by Henry I. Miller
Hoover Institution Press • 2000 • 112 pages • $14.95 paperback The Food and Drug Administration has a stranglehold on the introduction of new drugs, medical devices, and manufacturer-written information about products. The rationale is to assure quality and safety. Although consumers demand quality and safety assurance, the free-enterprise and tort system are supposedly unable [...]
1Jul2001 | Daniel B. Klein | 0 comments | Continued-
The Latest
Contraception: Insuring the Uninsurable
Update below. Controversy rages over the Obama administration’s mandate that all employers – including... Read More
The Snow Plowers’ Petition
The following might have happened in a small college town in upstate New York… In a cold and snowy... Read More
Super Bowl versus Education?
In the spirit of Super Bowl weekend I’d like to deconstruct a Facebook status update that a friend... Read More
Capitalism, Corporatism, and the Freed Market
When a front-running presidential contender tells the country that thanks to Barack Obama, “[w]e are... Read More
Creating Jobs versus Creating Value
Picking on New York Times columnist Paul Krugman is one of the largest participation sports on the Internet.... Read More
